Catalyst
Slingshot members are tracking this event:
Clearside Biomedical's (CLSD) Phase 2 preliminary data of Suprachoroidal CLS-TA - TYBEE in Diabetic Macular Edema (DME) expected in 2Q 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLSD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 31, 2018
Occurred Source:
http://ir.clearsidebio.com/news-releases/news-release-details/clearside-biomedical-announces-positive-topline-results-phase-2
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Suprachoroidal Cls-ta, Tybee, Diabetic Macular Edema
